SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,709.69 -143.21
( -0.19%)

Global Indices

Nasdaq

52,511.77 524.74
(1.01%)

Dow Jones

7,731.20 19.47
(0.25%)

Hang Seng

64,728.80 653.38
(1.02%)

Nikkei 225

10,751.68 18.68
(0.17%)

Forex

USD-INR

94.90 0.12
(0.13%)

EUR-INR

106.44 -0.03
(-0.02%)

GBP-INR

126.38 0.12
(0.10%)

JPY-INR

0.60 0.00
(-0.04%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Coral Laboratories Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524506

INE683E01017

585.7467787

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

9.88

187.35

EPS(TTM)

Face Value()

Div & Yield %

53.11

0.38

Particulars(INCOME)	Mar 2026 ( Cr)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)
Sales Turnover	85.90	115.01	83.66	78.12	75.61	96.57
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	85.90	115.01	83.66	78.12	75.61	96.57
Other Income	10.21	9.11	6.63	6.93	5.77	3.79
Stock Adjustments	6.97	-3.32	3.13	-3.64	-0.71	0.05
Total Income	103.08	120.80	93.42	81.41	80.67	100.41
EXPENDITURE :
Raw Materials	42.51	49.70	40.38	42.11	39.01	50.11
Power & Fuel Cost	2.49	3.16	3.05	3.10	2.55	2.05
Employee Cost	15.92	14.74	11.20	11.13	11.23	10.18
Other Manufacturing Expenses	4.82	4.22	3.96	4.55	4.01	5.81
Selling & Administrative Expenses	5.24	8.17	8.39	9.55	9.61	9.32
Miscellaneous Expenses	6.68	6.24	3.74	0.23	0.28	3.29
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	77.66	86.22	70.72	70.68	66.69	80.76
Operating Profit	25.42	34.58	22.71	10.75	13.99	19.64
Interest	0.17	0.10	0.00	0.34	0.14	0.04
Gross Profit	25.25	34.48	22.71	10.41	13.85	19.60
Depreciation	2.14	2.01	1.98	2.18	1.99	1.98
Profit Before Tax	23.11	32.47	20.73	8.23	11.86	17.62
Tax	5.78	8.33	4.91	1.82	2.75	4.50
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.95	-0.02	0.03	-0.04	0.06	-0.44
Reported Net Profit	16.38	24.16	15.79	6.45	9.05	13.55
Extraordinary Items	0.40	-0.57	-0.12	0.03	0.73	0.01
Adjusted Net Profit	15.98	24.73	15.91	6.42	8.32	13.54
Adjustment below Net Profit	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance brought forward	170.90	147.46	131.67	125.23	116.18	102.63
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.54	0.71	0.00	0.00	0.00	0.00
P & L Balance carried down	186.75	170.90	147.46	131.67	125.23	116.18
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	20.00	15.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	2.00	1.50	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	45.85	67.61	44.19	18.04	25.32	37.94
Earnings Per Share(Adj)-Unit Curr	45.85	67.61	44.19	18.04	25.32	37.94
Book Value-Unit Curr	585.33	563.19	496.83	433.29	436.81	382.48
Book Value(Adj)-Unit Curr	585.33	563.19	496.83	433.29	436.81	382.48

73,709.69 -143.21 ( -0.19%)

52,511.77 524.74 (1.01%)

7,731.20 19.47 (0.25%)

64,728.80 653.38 (1.02%)

10,751.68 18.68 (0.17%)

94.90 0.12 (0.13%)

106.44 -0.03 (-0.02%)

126.38 0.12 (0.10%)

0.60 0.00 (-0.04%)